Top compounds associated with response to MOCS3


Feature Type Standardized
Nominal ANOVA
mRNA semagacestat CTRPv2 pan-cancer AAC -0.093 0.01
mRNA lapatinib CCLE pan-cancer AAC 0.11 0.01
mRNA AEW541 CCLE pan-cancer AAC 0.11 0.01
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.09 0.02
mRNA BYL-719 CTRPv2 pan-cancer AAC 0.11 0.02
mRNA LBW242 CCLE pan-cancer AAC -0.11 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA SR8278 CTRPv2 pan-cancer AAC 0.3 0.02
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA AZD7762 CTRPv2 pan-cancer AAC -0.078 0.02
Download CSV